Gemigliptin Oxalate Monohydrate is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used to improve glycemic control in adults with type 2 diabetes by increasing incretin hormone levels, which stimulates… Read more
Gemigliptin Oxalate Monohydrate is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used to improve glycemic control in adults with type 2 diabetes by increasing incretin hormone levels, which stimulates insulin release and suppresses glucagon. This category provides access to high-quality reference standards essential for the comprehensive analysis of this active pharmaceutical ingredient. Pharmaceutical laboratories utilize these materials for rigorous method validation, impurity profiling, and quality control processes. The collection includes pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds required to ensure the accuracy and reliability of analytical testing throughout the drug development lifecycle. By incorporating these specialized standards into routine workflows, researchers can effectively monitor compound stability, detect trace-level degradation products, and verify chemical purity in compliance with regulatory standards for pharmaceutical manufacturing.